Exhibit 107
Calculation of Filing Fee Tables
424(b)(2)
(Form Type)
Boston Scientific Corporation
(Exact Name of Registrant as Specified in its Charter)
American Medical Systems Europe B.V.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered and Carry Forward Securities
|
Security Type |
Security Class Title |
Fee Calculation or Carry Forward Rule |
Amount Registered |
Proposed Maximum Offering Price Per Unit |
Maximum Aggregate Offering Price |
Fee Rate |
Amount of Registration Fee (1) |
Carry Forward Form Type |
Carry Forward File Number |
Carry Forward Initial effective date |
Filing Fee Previously Paid In Connection with Unsold Securities to be Carried Forward | |
| Newly Registered Securities | ||||||||||||
| Fees to Be Paid | Debt | 3.375% Notes due 2029 | 457(r) | €750,000,000 | 99.635% | €747,262,500 | 0.00014760 | $119,373.31 | ||||
| Fees to Be Paid | Debt | 3.500% Notes due 2032 | 457(r) | €1,250,000,000 | 99.696% | €1,246,200,000 | 0.00014760 | $199,077.31 | ||||
| Fees to Be Paid | Other | Guarantees | 457(n) | — | — | — | — | — (2) | ||||
| Carry Forward Securities | ||||||||||||
| Carry Forward Securities | ||||||||||||
| Total Offering Amounts | €1,993,462,500 | $318,450.62 | ||||||||||
| Total Fees Previously Paid | ||||||||||||
| Total Fee Offsets | ||||||||||||
| Net Fee Due | $318,450.62 | |||||||||||
(1) The filing fee is calculated in accordance with Rule 457(r) under the Securities Act of 1933, as amended, based upon a Euro-to-U.S. dollar exchange rate of €1 to $1.0823 as of February 22, 2024 as reported on Bloomberg.
(2) No separate consideration will be received for any guarantee of debt securities. Accordingly, pursuant to Rule 457(n) of the Securities Act of 1933, as amended, no separate filing fee is required.